|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,301.25 MXN | +1.15% |
|
+1.15% | +3.55% |
| 07-30 | Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials | RE |
| 07-28 | Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | -3.60% | +19.26% | +6.90% | +50.70% | +153.56% | +371.80% | +1,281.15% | 1,024B | |
| +0.21% | -2.68% | +0.93% | +12.84% | +23.87% | +53.20% | +51.79% | +48.87% | +104.43% | 618B | |
| -2.51% | -3.25% | -0.05% | +21.46% | +9.83% | +28.54% | +68.94% | +115.77% | +274.87% | 443B | |
| +0.06% | -0.42% | +7.54% | +11.06% | +7.74% | +37.53% | +30.67% | +0.93% | +42.87% | 349B | |
| -0.69% | -0.30% | -8.82% | -6.51% | -8.40% | +13.76% | +12.83% | +52.78% | +149.35% | 264B | |
| -7.37% | -4.40% | -5.40% | +10.25% | -5.76% | -0.74% | -44.28% | +5.69% | +60.93% | 209B | |
| -0.64% | +2.43% | +6.60% | +16.78% | +17.67% | +29.74% | +65.93% | +59.46% | +121.15% | 208B | |
| +0.40% | +1.92% | +4.73% | -5.01% | +0.44% | +6.47% | -29.77% | -41.58% | -32.97% | 143B | |
| +0.69% | +5.19% | +15.72% | +12.18% | +21.08% | +47.66% | +6.14% | -3.77% | -14.28% | 133B | |
| -0.95% | -0.05% | -4.20% | +12.54% | +5.24% | +3.24% | +37.20% | +136.68% | +385.85% | 121B | |
| -0.44% | +0.63% | +0.08% | +1.60% | +5.86% | +38.31% | +40.82% | +8.99% | -9.13% | 104B | |
| +2.34% | -2.05% | +1.94% | -6.70% | -9.97% | -7.31% | -22.89% | -14.28% | -2.36% | 103B | |
| -1.97% | -6.53% | -4.79% | -15.92% | -15.90% | -5.56% | +59.43% | +72.44% | +438.76% | 71.57B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -3.59% | -2.39% | +7.05% | +5.23% | +14.02% | +30.73% | +24.87% | +49.73% | +14.85% | 55.24B | |
| -0.81% | +4.32% | -1.94% | +26.28% | +29.83% | +70.87% | -9.29% | -4.45% | -50.13% | 54.3B | |
| -1.04% | +1.18% | +0.56% | +0.37% | -9.22% | -11.79% | +24.67% | -0.55% | +237.69% | 52.81B | |
| -1.44% | -0.06% | +3.65% | +5.58% | -3.07% | -0.57% | +10.09% | - | - | 43.08B | |
| -1.13% | +13.63% | +4.69% | +0.17% | +12.18% | +127.63% | +322.32% | +262.80% | -34.70% | 40.8B | |
| Average | -1.02% | +0.19% | +1.37% | +6.75% | +5.69% | +28.47% | +44.61% | +65.96% | +174.61% | 215.79B | |
| Weighted average by Cap. | -0.90% | -1.49% | +0.05% | +11.82% | +8.26% | +34.89% | +64.76% | +129.76% | +418.37% |
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
